| Financial Year |
March 31 2023 |
| Monetary Funds |
758,494,766.05 |
| Held-for-trading Financial Assets |
76,267,307.74 |
| Notes Receivable |
-- |
| Accounts Receivable |
356,961,314.28 |
| Advances to Suppliers |
26,826,461.33 |
| Other Receivables |
60,136,172.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,689,581,068.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
223,845,424.16 |
| Total Current Assets |
4,192,112,513.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
196,576,253.17 |
| Investment Properties |
7,109,819.55 |
| Fixed Assetes |
422,713,202.74 |
| Under-construction Projects |
35,870,999.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,460,355.05 |
| R&D expenses |
-- |
| Goodwill |
725,066,624.12 |
| Long-Term Deferred and Prepaid Expenses |
45,594,681.29 |
| Deferred Income Tax Assets |
28,517,926.62 |
| Other Non-Current Assets |
21,351,902.18 |
| Sub-Total of Non-Current Assets |
1,575,344,090.24 |
| Total Assets |
5,767,456,604.23 |
| Short-Term Loans |
449,237,493.62 |
| Trading Financial liabilities |
566,066,698.68 |
| Notes Payable |
-- |
| Accounts Payable |
208,713,337.11 |
| Accounts Received In Advance |
100,000.00 |
| Employee Compensation Payable |
22,457,808.62 |
| Taxes Payable |
67,770,591.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
214,103,024.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
69,302,507.99 |
| Other Current Liabilities |
46,409,315.54 |
| Sub-Total of Current Liabilities |
1,723,376,368.70 |
| Long-term Loans |
279,016,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
236,916.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
306,289,069.64 |
| Total Liabilities |
2,029,665,438.34 |
| Paid-In Capital(Or Share Stock) |
888,512,707.00 |
| Capital Surplus |
1,349,609,423.53 |
| Surplus Reserve |
241,298,488.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,307,811,466.65 |
| Minority Stockholder's Interest |
67,086,522.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,670,704,643.68 |
| Owner's Equity（Stockholder's Equity） |
3,737,791,165.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,767,456,604.23 |
